Trial Profile
Exploratory research on efficacy and safety of transarterial chemo-embolization with warmed miriplatin for unresectable hepatocellular carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2019
Price :
$35
*
At a glance
- Drugs Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 28 Dec 2019 Planned End Date changed from 31 May 2020 to 31 May 2025.
- 26 Dec 2017 Status changed from not yet recruiting to recruiting.
- 30 Jun 2017 New trial record